Carotid Atherosclerotic Plaque Matrix Metalloproteinase‐12–Positive Macrophage Subpopulation Predicts Adverse Outcome After Endarterectomy

Background Matrix metalloproteinase‐12 (MMP‐12) promotes atherosclerosis in animal models. MMP‐12 is expressed in only a subset of foam‐cell macrophages (FCMs) in human plaques. We investigated whether the prevalence of this MMP‐12–expressing subpopulation is a prognostic indicator of adverse outcom...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Heart Association 2012-12, Vol.1 (6), p.e001040-n/a
Hauptverfasser: Scholtes, Vincent P. W., Johnson, Jason L., Jenkins, Nicholas, Sala‐Newby, Graciela B., Vries, Jean‐Paul P. M., Borst, Gert Jan, Kleijn, Dominique P. V., Moll, Frans L., Pasterkamp, Gerard, Newby, Andrew C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Matrix metalloproteinase‐12 (MMP‐12) promotes atherosclerosis in animal models. MMP‐12 is expressed in only a subset of foam‐cell macrophages (FCMs) in human plaques. We investigated whether the prevalence of this MMP‐12–expressing subpopulation is a prognostic indicator of adverse outcome in patients after carotid endarterectomy (CEA). Methods and Results Serial sections of culprit lesions from 236 patients who underwent CEA and had undergone 3 years of clinical follow‐up were stained immunocytochemically for MMP‐12 and for CD68, and the MMP‐12/CD68 ratio was used to quantify the MMP‐12–expressing subpopulation. A high MMP‐12/CD68 ratio correlated with a high content of lipid and total macrophages and a low content of vascular smooth muscle cells, as well as with MMP‐8 (R=0.211, P=0.001), MMP‐9 (R=0.251, P
ISSN:2047-9980
2047-9980
DOI:10.1161/JAHA.112.001040